Latest News for ANPCF
Enbridge Inc (TSX:ENB) on Friday reported record financial results for 2025, driven by higher earnings across its operations, and reaffirmed its 2026...
Shares in CelLBxHealth PLC (AIM:CLBX, OTCQB:ANPCF, FRA:DWV) rose 3% to 1.08p on Thursday after the company announced it would discontinue its United States Food and Drug Administration establishment licence and device listing for its Parsortix system. The Guildford-based group, which provides circulating tumour cell intelligence tests and services to support cancer research and drug development, said the decision…
CelLBxHealth PLC (AIM:CLBX, OTCQB:ANPCF, FRA:DWV) has decided to discontinue maintenance of its United States Food and Drug Administration establishment licence and device listing for the Parsortix system as it seeks to strengthen cost discipline and match its regulatory approach with current commercial priorities. The Guildford-based group, which provides circulating tumour cell intelligence tests and services to…
CelLBxHealth PLC (AIM:CLBX, OTCQB:ANPCF, FRA:DWV) has decided to discontinue maintenance of its United States Food and Drug Administration establishment...
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for ANPCF.
Senate Trading
No Senate trades found for ANPCF.
U.S. House Trading
No House trades found for ANPCF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.